Globus Medical Inc. Class A

81.22+0.2700+0.33%Vol 541.69K1Y Perf 65.86%
Sep 24th, 2021 16:00 DELAYED
BID78.00 ASK82.10
Open80.52 Previous Close80.95
Pre-Market- After-Market81.22
 - -  - -%
Target Price
85.73 
Analyst Rating
Moderate Buy 1.73
Potential %
5.55 
Finscreener Ranking
★★★     49.50
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     52.02
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★+     63.05
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
91.69 
Earnings Rating
Buy
Market Cap8.19B 
Earnings Date
27th Oct 2021
Alpha0.01 Standard Deviation0.08
Beta1.08 

Today's Price Range

80.4881.44

52W Range

48.0084.23

5 Year PE Ratio Range

16.3052.60

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
0.62%
1 Month
4.52%
3 Months
4.85%
6 Months
33.83%
1 Year
65.86%
3 Years
48.62%
5 Years
259.70%
10 Years
-

TickerPriceChg.Chg.%
GMED81.220.27000.33
AAPL146.920.09000.06
GOOG2 852.6616.13000.57
MSFT299.35-0.2100-0.07
XOM57.590.51000.89
WFC47.920.12000.25
JNJ164.36-0.5000-0.30
FB352.967.00002.02
GE103.800.84000.82
JPM163.041.86001.15
Earnings HistoryEstimateReportedSurprise %
Q02 20210.450.5624.44
Q01 20210.360.4936.11
Q04 20200.510.5813.73
Q03 20200.310.4958.06
Q02 2020-0.110.07163.64
Q01 20200.400.29-27.50
Q04 20190.520.49-5.77
Q03 20190.430.430.00
Earnings Per EndEstimateRevision %Trend
9/2021 QR0.450.00-
12/2021 QR0.50-1.96Negative
12/2021 FY2.005.82Positive
12/2022 FY2.170.46Positive
Next Report Date27th Oct 2021
Estimated EPS Next Report0.45
Estimates Count7
EPS Growth Next 5 Years %10.60
Volume Overview
Volume541.69K
Shares Outstanding100.89M
Shares Float77.45M
Trades Count6.81K
Dollar Volume46.14M
Avg. Volume455.00K
Avg. Weekly Volume415.69K
Avg. Monthly Volume498.20K
Avg. Quarterly Volume460.19K

Globus Medical Inc. Class A (NYSE: GMED) stock closed at 81.22 per share at the end of the most recent trading day (a 0.33% change compared to the prior day closing price) with a volume of 542.02K shares and market capitalization of 8.19B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 2200 people. Globus Medical Inc. Class A CEO is David M. Demski.

The one-year performance of Globus Medical Inc. Class A stock is 65.86%, while year-to-date (YTD) performance is 24.53%. GMED stock has a five-year performance of 259.7%. Its 52-week range is between 48 and 84.23, which gives GMED stock a 52-week price range ratio of 91.69%

Globus Medical Inc. Class A currently has a PE ratio of 44.80, a price-to-book (PB) ratio of 4.97, a price-to-sale (PS) ratio of 8.61, a price to cashflow ratio of 32.10, a PEG ratio of 2.32, a ROA of 10.90%, a ROC of 12.37% and a ROE of 12.07%. The company’s profit margin is 20.09%, its EBITDA margin is 31.90%, and its revenue ttm is $927.90 Million , which makes it $9.20 revenue per share.

Of the last four earnings reports from Globus Medical Inc. Class A, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.45 for the next earnings report. Globus Medical Inc. Class A’s next earnings report date is 27th Oct 2021.

The consensus rating of Wall Street analysts for Globus Medical Inc. Class A is Moderate Buy (1.73), with a target price of $85.73, which is +5.55% compared to the current price. The earnings rating for Globus Medical Inc. Class A stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Globus Medical Inc. Class A has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Globus Medical Inc. Class A has a Buy technical analysis rating based on Technical Indicators (ADX : 6.20, ATR14 : 1.72, CCI20 : -29.52, Chaikin Money Flow : 0.04, MACD : 0.06, Money Flow Index : 38.64, ROC : -3.38, RSI : 52.80, STOCH (14,3) : 48.14, STOCH RSI : 0.94, UO : 44.60, Williams %R : -51.87), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Globus Medical Inc. Class A in the last 12-months were: Ann D. Rhoads (Sold 0 shares of value $-163 993 ), Daniel T. Scavilla (Sold 0 shares of value $-1 313 500 ), Daniel T. Scavilla (Sold 100 000 shares of value $7 841 224 ), David D. Davidar (Sold 42 000 shares of value $2 520 000 ), David M. Demski (Sold 0 shares of value $-10 240 445 ), David M. Demski (Sold 482 597 shares of value $32 931 951 ), James R. Tobin (Sold 0 shares of value $-1 094 250 ), James R. Tobin (Sold 25 000 shares of value $1 799 000 ), Keith W. Pfeil (Sold 0 shares of value $-1 839 439 ), Keith W. Pfeil (Sold 35 833 shares of value $2 701 114 ), Kelly G. Huller (Sold 0 shares of value $-22 560 ), Kelly G. Huller (Sold 2 000 shares of value $132 300 ), Lemaitre Dan (Sold 0 shares of value $-173 532 ), Lemaitre Dan (Sold 15 384 shares of value $961 039 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (63.64 %)
7 (63.64 %)
6 (60.00 %)
Moderate Buy
1 (9.09 %)
1 (9.09 %)
1 (10.00 %)
Hold
2 (18.18 %)
2 (18.18 %)
2 (20.00 %)
Moderate Sell
1 (9.09 %)
1 (9.09 %)
1 (10.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.73
Moderate Buy
1.73
Moderate Buy
1.80

Globus Medical Inc. Class A

Globus Medical is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which includes medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which includes advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

CEO: David M. Demski

Telephone: +1 610 930-1800

Address: 2560 General Armistead Avenue, Audubon 19403, PA, US

Number of employees: 2 200

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

44%56%

Bearish Bullish

68%32%

TipRanks News for GMED

Thu, 05 Aug 2021 16:31 GMT Globus Medical (GMED) Gets a Hold Rating from Morgan Stanley

- TipRanks. All rights reserved.

Thu, 05 Aug 2021 16:31 GMT Citigroup Believes Globus Medical (GMED) Still Has Room to Grow

- TipRanks. All rights reserved.

News

Stocktwits